Immutep LTD ADR buy Mori8
Start price
20.09.16
/
50%
€2.62
Target price
27.09.16
€3.60
Performance (%)
0.00%
End price
27.09.16
€2.62
Summary
This prediction ended on 27.09.16 with a price of €2.62. The BUY prediction by Mori8 closed unchanged from the start price. Mori8 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Immutep LTD ADR | 2.308% | 2.308% | 40.741% | 44.565% |
| iShares Core DAX® | 0.721% | 4.566% | 24.333% | 64.224% |
| iShares Nasdaq 100 | -0.413% | 1.884% | 8.848% | 107.611% |
| iShares Nikkei 225® | 3.500% | 7.196% | 24.030% | 57.276% |
| iShares S&P 500 | 0.489% | 2.436% | 6.048% | 67.009% |
Comments by Mori8 for this prediction
In the thread Immutep LTD ADR diskutieren
Das Unternehmen konzentriert sich auf die Immuntherapie von Krebs-Forschung.
Brokers have set a twelve-month consensus target price of $5.00 for the company, according to Zacks.
(Vom Mitglied beendet)


